clopidogrel and Dyspnea

clopidogrel has been researched along with Dyspnea in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (15.79)29.6817
2010's25 (65.79)24.3611
2020's7 (18.42)2.80

Authors

AuthorsStudies
Bai, N; Ma, Y; Niu, Y; Shang, YS; Wang, ZL; Zhong, PY1
Bergh, N; Myredal, A; Nivedahl, P; Petzold, M; Wallerstedt, SM; Wartenberg, C; Zarin, S1
An, HJ; He, YY; Li, S; Sheng, XY; Ye, YF; Zhao, JL1
Gimbel, ME; Kelder, JC; Nguyen, TA; Ten Berg, JM; Vos, GJA1
Graham, MM; Har, B; James, MT; Koshman, SL; Turgeon, RD; Wilton, SB; Youngson, E1
Li, O; Xu, W; Zhang, B; Zhang, N1
Bikdeli, B; Cho, J; Gupta, A; Hripcsak, G; Kim, J; Krumholz, HM; Londhe, A; Madigan, D; Park, J; Park, RW; Reich, CG; Rho, Y; Ryan, PB; Schuemie, M; Siapos, A; Suchard, MA; Weaver, J; You, SC1
Bhatt, DL; Day, JRS; Gibson, CM; Hamm, CW; Mahaffey, KW; Parker, WA; Prats, J; Price, MJ; Steg, PG; Stone, GW; Storey, RF; White, HD1
Baele, P; Kahn, D; Lamberts, V; Liistro, G1
Billinger, M; Blöchlinger, S; Heg, D; Hunziker, L; Karagiannis, A; Koskinas, KC; Moro, C; Moschovitis, A; Pilgrim, T; Praz, F; Räber, L; Räsänen, M; Seiler, C; Stortecky, S; Temperli, F; Valgimigli, M; Windecker, S; Zanchin, C; Zanchin, T1
Fredgart, M; Gill, S1
Cui, XR; Jia, M; Li, RB; Wang, D; Yang, XH; Zhang, JD1
Jüni, P; Serruys, P; Valgimgli, M; Vranckx, P; Windecker, S1
Martí, D; Sanmartín, M1
DiNicolantonio, JJ; Serebruany, VL; Sibbing, D1
Caldeira, D; Ferreira, JJ; Pinto, FJ1
Ge, J; Qian, J; Wang, Q; Wu, H; Zhou, J1
Andell, P; Cannon, CP; Cyr, DD; Erlinge, D; Himmelmann, A; Husted, S; James, SK; Keltai, M; Koul, S; Santoso, A; Steg, PG; Storey, RF; Wallentin, L1
Cajigas, HR; Godfrey, A1
Aribaş, A; Aygül, N; Can, I; Ozdemir, K1
Atar, D; Kuliczkowski, W; Pokov, I; Serebruany, V; Vahabi, J1
Hjemdahl, P; Malmström, RE1
Parker, T1
Becker, RC; Budaj, A; Cannon, CP; Emanuelsson, H; Freij, A; Harrington, RA; Held, C; Horrow, J; Husted, S; James, S; Katus, H; Mahaffey, KW; Scirica, BM; Skene, A; Steg, PG; Storey, RF; Thorsén, M; Wallentin, L1
Tomoda, H1
Cimino, E; Conca, P; Coppola, A; De Simone, C; Di Capua, M; Di Minno, G; Guida, A; Morisco, C; Tufano, A1
Bliden, KP; Butler, K; Ecob, R; Gurbel, PA; Karunakaran, A; Patil, SB; Storey, RF; Tantry, US; Teng, R; Wei, C1
Abergel, E; Nikolsky, E1
Goldhaber, SZ; Maron, BA; Shekar, PS1
Becker, RC; Cairns, R; Cannon, CP; Cools, F; Cooper, A; Emanuelsson, H; Harrington, RA; Husted, S; James, SK; Khurmi, NS; Steg, PG; Storey, RF; Wallentin, L1
Bonafede, M; Deitelzweig, SB; Gdovin Bergeson, J; Graham, J; Jing, Y; Liffmann, D; Makenbaeva, D1
Al-Rashid, F; Erbel, R; Jakob, H; Kahlert, P; Konorza, TF; Plicht, B; Thielmann, M; Wendt, D1
Abouzgheib, W; Bartter, T; Meena, N; Shweihat, YR1
Burgess, S; Juergens, CP; Mallard, TA1
Lincoff, AM; May, CH1
DiNicolantonio, JJ; Serebruany, VL1
Cheong, MA; Kim, DW; Yi, HJ1
Cattaneo, M; Faioni, EM1

Reviews

11 review(s) available for clopidogrel and Dyspnea

ArticleYear
Comparison of Ticagrelor With Clopidogrel in East Asian Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Journal of cardiovascular pharmacology, 2022, 05-01, Volume: 79, Issue:5

    Topics: Acute Coronary Syndrome; Asian People; Clopidogrel; Dyspnea; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Ticagrelor; Treatment Outcome

2022
Efficacy and Safety of Clopidogrel Versus Ticagrelor as Part of Dual Antiplatelet Therapy in Acute Coronary Syndrome-A Systematic Review and Meta-analysis.
    Journal of cardiovascular pharmacology, 2022, 05-01, Volume: 79, Issue:5

    Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Dyspnea; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thrombosis; Ticagrelor; Treatment Outcome

2022
High-Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta-Analysis of Randomized Trials.
    Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:8

    Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Dyspnea; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticagrelor; Treatment Outcome

2022
The risk of dyspnea in patients treated with third-generation P2Y
    BMC cardiovascular disorders, 2020, 03-17, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clopidogrel; Dyspnea; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Ticagrelor; Young Adult

2020
Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis.
    BMC cardiovascular disorders, 2018, 11-29, Volume: 18, Issue:1

    Topics: Acute Coronary Syndrome; Clopidogrel; Dyspnea; Hemorrhage; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Ticagrelor; Treatment Outcome

2018
Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond.
    Cardiology, 2014, Volume: 127, Issue:1

    Topics: Acute Lung Injury; Adenosine; Adenosine Monophosphate; Administration, Oral; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Sulfonamides; Ticagrelor; Ticlopidine; Transfusion Reaction

2014
Dyspnea and reversibility profile of P2Y₁₂ antagonists: systematic review of new antiplatelet drugs.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2014, Volume: 14, Issue:4

    Topics: Adenosine; Adenosine Monophosphate; Clopidogrel; Dyspnea; Humans; Incidence; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Sulfonamides; Thiophenes; Ticagrelor; Ticlopidine

2014
Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome.
    Vascular health and risk management, 2010, Oct-21, Volume: 6

    Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Blood Platelets; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine; Treatment Outcome

2010
Review of ticagrelor in the management of acute coronary syndromes.
    Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:10

    Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Dyspnea; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine

2012
Safety profile and bleeding risk of ticagrelor compared with clopidogrel.
    Expert opinion on drug safety, 2012, Volume: 11, Issue:6

    Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Dyspnea; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticagrelor; Ticlopidine

2012
Why does ticagrelor induce dyspnea?
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:6

    Topics: Adenosine; Clopidogrel; Dyspnea; Humans; Models, Biological; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Sensory Receptor Cells; Ticagrelor; Ticlopidine

2012

Trials

5 trial(s) available for clopidogrel and Dyspnea

ArticleYear
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study.
    Thrombosis and haemostasis, 2017, 06-02, Volume: 117, Issue:6

    Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Occlusion; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Percutaneous Coronary Intervention; Receptors, Purinergic P2Y12; Survival Analysis; Ticlopidine; Treatment Outcome; Withholding Treatment

2017
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
    Journal of the American Heart Association, 2015, Oct-09, Volume: 4, Issue:10

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Dyspnea; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome

2015
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
    The New England journal of medicine, 2009, Sep-10, Volume: 361, Issue:11

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Double-Blind Method; Dyspnea; Electrocardiography; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Stroke; Ticagrelor; Ticlopidine

2009
Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study.
    Journal of the American College of Cardiology, 2010, Jul-13, Volume: 56, Issue:3

    Topics: Adenosine; Aged; Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Dyspnea; Female; Heart; Humans; Lung; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Ticagrelor; Ticlopidine

2010
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes.
    European heart journal, 2011, Volume: 32, Issue:23

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Double-Blind Method; Dyspnea; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Treatment Outcome

2011

Other Studies

22 other study(ies) available for clopidogrel and Dyspnea

ArticleYear
Reasons for early discontinuing or switching of antiplatelet therapy in elderly patients after acute coronary syndrome.
    Coronary artery disease, 2020, Volume: 31, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Artery Bypass; Deprescriptions; Drug Substitution; Dual Anti-Platelet Therapy; Dyspnea; Factor Xa Inhibitors; Female; Humans; Male; Non-ST Elevated Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor

2020
Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    JAMA internal medicine, 2020, 03-01, Volume: 180, Issue:3

    Topics: Acute Coronary Syndrome; Age Factors; Aged; Clopidogrel; Dyspnea; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor; Treatment Outcome

2020
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    JAMA, 2020, 10-27, Volume: 324, Issue:16

    Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Algorithms; Aspirin; Case-Control Studies; Cause of Death; Clopidogrel; Databases, Factual; Dyspnea; Female; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Myocardial Infarction; Network Meta-Analysis; Percutaneous Coronary Intervention; Propensity Score; Purinergic P2Y Receptor Antagonists; Recurrence; Republic of Korea; Retrospective Studies; Stroke; Ticagrelor; United States

2020
Dyspnea or Cheyne-Stokes respiration associated with Ticagrelor?
    Sleep medicine, 2018, Volume: 43

    Topics: Aged; Cheyne-Stokes Respiration; Clopidogrel; Dyspnea; Humans; Male; Myocardial Infarction; Polysomnography; Ticagrelor

2018
Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
    Circulation. Cardiovascular interventions, 2018, Volume: 11, Issue:5

    Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Drug Administration Schedule; Drug Substitution; Dyspnea; Female; Hemorrhage; Humans; Male; Medication Adherence; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Registries; Switzerland; Tertiary Care Centers; Ticagrelor; Time Factors; Treatment Outcome

2018
Left ventricular mural thrombus despite treatment with dabigatran and clopidogrel.
    BMJ case reports, 2018, May-30, Volume: 2018

    Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Fatal Outcome; Heart Diseases; Heart Failure; Humans; Male; Thrombosis; Ticlopidine; Warfarin

2018
Dyspnoea in the GLOBAL LEADERS trial - Authors' reply.
    Lancet (London, England), 2019, 06-15, Volume: 393, Issue:10189

    Topics: Aspirin; Clopidogrel; Drug-Eluting Stents; Dyspnea; Humans; Ticagrelor

2019
Dyspnoea in the GLOBAL LEADERS trial.
    Lancet (London, England), 2019, 06-15, Volume: 393, Issue:10189

    Topics: Aspirin; Clopidogrel; Drug-Eluting Stents; Dyspnea; Humans; Ticagrelor

2019
First report of stent thrombosis after a switch therapy resulting from ticagrelor-related dyspnea.
    International journal of cardiology, 2014, Oct-20, Volume: 176, Issue:3

    Topics: Adenosine; Aged; Clopidogrel; Drug Substitution; Dyspnea; Humans; Male; Purinergic P2Y Receptor Antagonists; Stents; Thrombosis; Ticagrelor; Ticlopidine

2014
A 55-Year-Old Woman With Pulmonary Hypertension, Worsening Dyspnea, and Chest Pain.
    Chest, 2014, Volume: 145, Issue:3

    Topics: Angina Pectoris; Aspirin; Clopidogrel; Compartment Syndromes; Coronary Vessels; Diagnosis, Differential; Dyspnea; Female; Humans; Hypertension, Pulmonary; Middle Aged; Patient Care Management; Platelet Aggregation Inhibitors; Pulmonary Artery; Ticlopidine; Treatment Outcome

2014
Antiaggregant and anticoagulant therapy of free-floating thrombus in left atrium.
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2008, Jun-07, Volume: 8, Issue:3

    Topics: Adult; Anticoagulants; Aspirin; Clopidogrel; Diagnosis, Differential; Dyspnea; Echocardiography, Transesophageal; Female; Heart Atria; Heart Diseases; Heparin; Humans; Platelet Aggregation Inhibitors; Radiography; Thrombosis; Ticlopidine; Warfarin

2008
Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stenting.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:2

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Therapy, Combination; Dyspnea; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Risk Factors; Stents; Surveys and Questionnaires; Thrombosis; Ticlopidine

2008
Dyspnea and antiplatelet drugs: little cause for concern with clopidogrel.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:4

    Topics: Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Safety; Ticlopidine

2008
Case of the month. Idiopathic dilated cardiomyopathy.
    JAAPA : official journal of the American Academy of Physician Assistants, 2009, Volume: 22, Issue:7

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiography; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Clopidogrel; Diuretics; Dyspnea; Echocardiography; Electrocardiography; Furosemide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Potassium; Propanolamines; Pyrroles; Spironolactone; Ticlopidine

2009
Ticagrelor versus clopidogrel in acute coronary syndromes.
    The New England journal of medicine, 2009, Dec-10, Volume: 361, Issue:24

    Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Ticagrelor; Ticlopidine

2009
Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment.
    Thrombosis and haemostasis, 2010, Volume: 103, Issue:6

    Topics: Acute Coronary Syndrome; Anticoagulants; Clopidogrel; Coagulants; Comorbidity; Coronary Angiography; Dyspnea; Factor VIII; Fatal Outcome; Hemophilia A; Heparin, Low-Molecular-Weight; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Practice Guidelines as Topic; Renal Insufficiency; Ticlopidine

2010
Paradoxical embolism.
    Circulation, 2010, Nov-09, Volume: 122, Issue:19

    Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Dyspnea; Echocardiography, Transesophageal; Embolism, Paradoxical; Female; Heart Atria; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Walking

2010
Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome.
    Hospital practice (1995), 2011, Volume: 39, Issue:3

    Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Costs and Cost Analysis; Diagnostic Techniques and Procedures; Drug Therapy, Combination; Dyspnea; Emergency Service, Hospital; Female; Humans; Insurance Claim Review; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine

2011
Transient increase in pressure gradients after termination of dual antiplatelet therapy in a patient after transfemoral aortic valve implantation.
    Circulation. Cardiovascular interventions, 2012, Volume: 5, Issue:2

    Topics: Aged; Aortic Valve Stenosis; Aspirin; Cardiac Catheterization; Clopidogrel; Dyspnea; Echocardiography, Doppler; Femoral Artery; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Male; Platelet Aggregation Inhibitors; Recovery of Function; Ticlopidine; Withholding Treatment

2012
Is chest tube insertion with ultrasound guidance safe in patients using clopidogrel?
    Respirology (Carlton, Vic.), 2012, Volume: 17, Issue:8

    Topics: Aged; Chest Tubes; Clopidogrel; Contraindications; Dyspnea; Female; Humans; Male; Platelet Aggregation Inhibitors; Pleural Effusion; Respiratory Insufficiency; Retrospective Studies; Thoracostomy; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional

2012
Angiotensin receptor blockers worsen renal function and dyspnea on ticagrelor: a potential ticagrelor-angiotensin receptor blocker interaction?
    Clinical cardiology, 2012, Volume: 35, Issue:11

    Topics: Adenosine; Angiotensin II Type 1 Receptor Blockers; Clopidogrel; Drug Interactions; Dyspnea; Glomerular Filtration Rate; Hemorrhage; Humans; Kidney; Kidney Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Ticagrelor; Ticlopidine; United States; United States Food and Drug Administration

2012
Reversible shortness of breath caused by the antiplatelet agent, clopidogrel.
    Journal of neurosurgical anesthesiology, 2013, Volume: 25, Issue:1

    Topics: Aspirin; Cilostazol; Clopidogrel; Dyspnea; Embolization, Therapeutic; Endovascular Procedures; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Ticlopidine

2013